{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T18:19:59Z","timestamp":1788200399064,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","ejradiology.com","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ejrad.2024.111436","type":"journal-article","created":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T08:50:45Z","timestamp":1711097445000},"page":"111436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["MRI in-bore biopsy following MRI\/US fusion-guided biopsy in patients with persistent suspicion of clinically significant prostate cancer"],"prefix":"10.1016","volume":"175","author":[{"given":"M.","family":"Quentin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Boschheidgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Radtke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Spohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Ullrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Drewes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Valentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Lakes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Al-Monajjed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Arsov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Albers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Antoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7476-292X","authenticated-orcid":false,"given":"L.","family":"Schimm\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejrad.2024.111436_b0005","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jama.2014.17942","article-title":"Comparison of MR\/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer","volume":"313","author":"Siddiqui","year":"2015","journal-title":"JAMA \u2013 J. Am. Med. Assoc."},{"key":"10.1016\/j.ejrad.2024.111436_b0010","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1007\/s00261-015-0353-8","article-title":"Recent advances in image-guided targeted prostate biopsy","volume":"40","author":"Brown","year":"2015","journal-title":"Abdom Imag."},{"key":"10.1016\/j.ejrad.2024.111436_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2021.109587","article-title":"Reasons for missing clinically significant prostate cancer by targeted magnetic resonance imaging\/ultrasound fusion-guided biopsy","volume":"137","author":"Klingebiel","year":"2021","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.ejrad.2024.111436_b0020","first-page":"241","article-title":"PIRADS-5 cases with negative targeted MRI\/US fusion-guided biopsy","volume":"194","author":"Kasprowski","year":"2022","journal-title":"Rofo."},{"key":"10.1016\/j.ejrad.2024.111436_b0025","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2214\/AJR.15.14579","article-title":"MRI-Guided In-Bore Biopsy: Differences Between Prostate Cancer Detection and Localization in Primary and Secondary Biopsy Settings","volume":"206","author":"Schimmoller","year":"2016","journal-title":"AJR. Am. J. Roentgenol."},{"issue":"2019","key":"10.1016\/j.ejrad.2024.111436_b0030","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","article-title":"Update of Prostate Imaging Reporting and Data System Version 2","volume":"76","author":"Turkbey","year":"2019","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejrad.2024.111436_b0035","doi-asserted-by":"crossref","unstructured":"J.I. Epstein, L. Egevad, M.B. Amin, B. Delahunt, J.R. Srigley, P.A. Humphrey, The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System, Am. J. Surg. Pathol. 40 (2016) 244\u2013252. doi:10.1097\/PAS.0000000000000530.","DOI":"10.1097\/PAS.0000000000000530"},{"key":"10.1016\/j.ejrad.2024.111436_b0040","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41391-021-00449-7","article-title":"Diagnostic accuracy of magnetic resonance imaging targeted biopsy techniques compared to transrectal ultrasound guided biopsy of the prostate: a systematic review and meta-analysis","volume":"25","author":"Bass","year":"2022","journal-title":"Prostate Cancer Prost. Dis."},{"key":"10.1016\/j.ejrad.2024.111436_b0045","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.eururo.2016.07.041","article-title":"Comparing three different techniques for magnetic resonance imaging-targeted prostate biopsies: a systematic review of in-bore versus magnetic resonance imaging-transrectal ultrasound fusion versus cognitive registration. Is there a preferred technique?","volume":"71","author":"Wegelin","year":"2017","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejrad.2024.111436_b0050","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.2214\/AJR.20.25207","article-title":"In-bore versus fusion MRI-targeted biopsy of PI-RADS category 4 and 5 lesions: a retrospective comparative analysis using propensity score weighting","volume":"217","author":"Prince","year":"2021","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.ejrad.2024.111436_b0055","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.euo.2018.08.022","article-title":"Magnetic resonance imaging-guided in-bore and magnetic resonance imaging-transrectal ultrasound fusion targeted prostate biopsies: an adjusted comparison of clinically significant prostate cancer detection rate","volume":"2","author":"Costa","year":"2019","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.ejrad.2024.111436_b0060","doi-asserted-by":"crossref","first-page":"660","DOI":"10.2214\/AJR.19.22455","article-title":"3-T multiparametric MRI followed by in-bore MR-guided biopsy for detecting clinically significant prostate cancer after prior negative transrectal ultrasound-guided biopsy","volume":"215","author":"Hosseiny","year":"2020","journal-title":"AJR Am. J. Roentgenol."},{"issue":"297","key":"10.1016\/j.ejrad.2024.111436_b0065","first-page":"e9","article-title":"The utility of in-bore multiparametric magnetic resonance-guided biopsy in men with negative multiparametric magnetic resonance-ultrasound software-based fusion targeted biopsy","volume":"39","author":"Perrin","year":"2021","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.ejrad.2024.111436_b0070","doi-asserted-by":"crossref","first-page":"e190078","DOI":"10.1148\/rycan.2020190078","article-title":"In-bore MRI-guided prostate biopsies in patients with prior positive transrectal US\u2013guided biopsy results: pathologic outcomes and predictors of missed cancers","volume":"2","author":"Elfatairy","year":"2020","journal-title":"Radiol. Imag. Cancer."},{"key":"10.1016\/j.ejrad.2024.111436_b0075","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/pcan.2017.34","article-title":"Changes in prostate cancer detection rate of MRI-TRUS fusion vs systematic biopsy over time: evidence of a learning curve","volume":"204(20)","author":"Calio","year":"2017","journal-title":"Prost. Can. Prost. Dis."},{"key":"10.1016\/j.ejrad.2024.111436_b0080","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.juro.2016.06.079","article-title":"Prostate magnetic resonance imaging and magnetic resonance imaging targeted biopsy in patients with a prior negative biopsy: a consensus statement by AUA and SAR","volume":"196","author":"Rosenkrantz","year":"2016","journal-title":"J. Urol."},{"key":"10.1016\/j.ejrad.2024.111436_b0085","doi-asserted-by":"crossref","unstructured":"S. Gillessen, A. Bossi, I.D. Davis, J. de Bono, K. Fizazi, N.D. James, N. Mottet, et al. Management of patients with advanced prostate cancer. Part I: Intermediate-\/high-risk and locally advanced disease, biochemical relapse, and side effects of hormonal treatment: report of the advanced prostate cancer consensus conference 2022, Eur. Urol. 83 (2023) 267\u2013293. doi:10.1016\/J.EURURO.2022.11.002.","DOI":"10.1016\/j.eururo.2022.11.002"},{"key":"10.1016\/j.ejrad.2024.111436_b0090","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.juro.2015.03.025","article-title":"Accuracy of magnetic resonance imaging\/ultrasound fusion targeted biopsies to diagnose clinically significant prostate cancer in enlarged compared to smaller prostates","volume":"194","author":"De Gorski","year":"2015","journal-title":"J. Urol."},{"key":"10.1016\/j.ejrad.2024.111436_b0095","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.eururo.2016.12.006","article-title":"Why and where do we miss significant prostate cancer with multi-parametric magnetic resonance imaging followed by magnetic resonance-guided and transrectal ultrasound-guided biopsy in biopsy-na\u00efve men?","volume":"71","author":"Schouten","year":"2017","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejrad.2024.111436_b0100","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.euo.2021.06.001","article-title":"Managing discordant findings between multiparametric magnetic resonance imaging and transrectal magnetic resonance imaging-directed prostate biopsy-the key role of magnetic resonance imaging-directed transperineal biopsy","volume":"5","author":"Bajeot","year":"2022","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.ejrad.2024.111436_b0105","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.euros.2022.09.007","article-title":"Clinical trial protocol for PERFECT: a randomised controlled trial comparing the efficiency and tolerance of transperineal fusion versus transrectal imaging-targeted prostate biopsies (CCAFU-PR1 study)","volume":"45","author":"Touzani","year":"2022","journal-title":"Eur. Urol. Open Sci."},{"key":"10.1016\/j.ejrad.2024.111436_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2021.109785","article-title":"In-bore MRI-guided prostate biopsy in a patient group with PI-RADS 4 and 5 targets: a single center experience","volume":"141","author":"Vural","year":"2021","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.ejrad.2024.111436_b0115","first-page":"265","article-title":"Association between prostate size and MRI determined quantitative prostate zonal measurements","volume":"14","author":"Sellers","year":"2022","journal-title":"Res. Rep. Urol."}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X24001529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X24001529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T15:20:52Z","timestamp":1729092052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X24001529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":23,"alternative-id":["S0720048X24001529"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2024.111436","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MRI in-bore biopsy following MRI\/US fusion-guided biopsy in patients with persistent suspicion of clinically significant prostate cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2024.111436","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111436"}}